Gradient
EH&S Nano News
Volume 5, No. 1
www.ehsnanonews.com
February 2010

Editor:
Barbara D. Beck, Ph.D., DABT, FATS
Dr. Beck directs Gradient's nanotechnology, toxicology, and risk assessment practices.

Associate Editor:
Christopher M. Long, Sc.D

Recent Government Briefs

New National Toxicology Database Records on Nanomaterials

The National Library of Medicine (NLM) has recently added a set of nanomaterial records to its Hazardous Substances Data Bank (HSDB). The HSDB is a publically available database that provides toxicology information on human exposure, environmental fate, and regulatory requirements for over 5,000 different chemicals. The database is populated with information from books, government documents, technical reports, and selected primary literature. The information contained in each record is subject to peer-review by a committee of experts familiar with the subject material. Similar to the existing records in the HSDB, the nanomaterial records contain information on toxicity, manufacturing and use, chemical and physical properties, and environmental fate and exposure. There are currently seven HSDB nanomaterial records (carbon nanotubes, fullerenes, silver nanoparticles, iron nanoparticles, titanium oxide nanoparticles, zinc oxide nanoparticles, and cerium oxide nanoparticles). In addition to the seven records, information on hollow, spherical or ellipsoidal carbon nanostructures may be found in the fullerenes record, and information on tubular or lattice materials may be found in the carbon nanotubes record.

The HSDB and nanomaterial records are available at: http://toxnet.nlm.nih.gov/


US EPA Proposes a Second SNUR for Multi-Walled Carbon Nanotubes

As we described in a previous issue of our newsletter (link), on November 6, 2009, the US Environmental Protection Agency (US EPA) published a proposed significant new use rule for multi-walled carbon nanotubes (MWCNTs) under Section 5(a)(2) of the Toxic Substances Control Act (TSCA) for anyone intending to manufacture MWCNTs. Similarly, on February 3, 2010, the US EPA published a second proposed SNUR for MWCNTs, which would require individuals who also import or process MWCNTs for any significant new use to notify US EPA at least 90 days prior to the activity. This would provide US EPA an opportunity to evaluate the intended use and, if necessary, to prohibit or limit the activity before it occurs. Comments for this second proposal are due by March 5, 2010.

The US EPA "Proposed Significant New Use Rule for Multi-walled Carbon Nanotubes" (40 CFR Part 721 [EPA-HQ-OPPT-2009-0686; FRL-8796-7]) may be viewed in its entirety at: http://www.regulations.gov/


Manufacturers of Carbon Nanotubes in California Respond

The state of California (CA) has recently made available the responses to the Department of Toxic Substances Control (DTSC) formal request for information from manufacturers of carbon nanotubes (CNTs). The DTSC defines manufacturers as those who produce or import carbon nanotubes (CNT) in the state of CA, including academic institutions doing CNT research, and those manufacturers who are involved in producing or importing CNTs in their chemical form. In a January 2009 letter, the DTSC requested information on what products CNTs are used in; what sampling, detection and measurement methods are employed; what end-of life disposal methods are employed; what personal protective equipment is used; and is the discarded material produced by the manufacturer treated as a hazardous waste. According to DTSC, this information will be used in future assessments of environmental and human health risk. As of the publication of this newsletter, 16 of 24 organizations, representing government agencies, universities, and industry have complied with this information request. The letters are publically available on the Nanomaterials Information Call-In web page.

Submitted Information for the Carbon Nanotube Information Call-in is available at: http://www.dtsc.ca.gov/

Back to top

Reports, Reviews, White Papers, and Books

Nanomaterials and Immune Function

Chang, C.

A recent paper in the Journal of Autoimmunity by Christopher Chang, of the School of Medicine at the University of California at Davis, reviews how in vitro and in vivo studies are showing how nanoparticles (as well as ultra fine particles; UFP) may be activating proinflammatory cytokines, chemokines, and adhesion molecules by recruiting a number of inflammatory cell types (e.g., basophils, macrophages, dendritic cells, T cells, neutrophils and eosinophils). Chang describes how these changes may affect immune defense as well as non-immunologic functions. He also describes how the immune system damage can lead to autoimmune, allergic and even neoplastic disease states. Chang reviews many of the current applications of nanoparticles and how these materials are being used in virtually all industries (e.g., food science, genetic engineering, cosmetics, applied physics, device physics, health, textile, materials science, colloid science, and chemical, mechanical, biological, and electrical engineering). While nanoparticles are similar in size to many ambient ultrafine particles, Chang states that the risk of nanomaterials may be much lower due to the more homogeneous nature of nanoparticle preparations. Chang notes that further research is needed to establish safe exposure levels for this important new class of particulates.

More information about this article is available here.


Nanotoxicology and Nomenclature

Aitken, R; Borm, P; Donaldson, K; Ichihara, G; Loft, Steffen; Marano, F; Maynard, A; Oberdörster, G; Stamm, H; Stone, V; Tran, L; Wallin, H.

A recent paper in the journal Nanotoxicology is focused on how the term "nanoparticles" is used indiscriminately in the titles of peer-reviewed scientific papers, and how this affects the perception of risk when these papers are described by the popular press (i.e., newspapers, television, radio, etc.). For example, the 12 authors of this review describe the 2009 paper published in the International Journal of Toxicology by Song et al., entitled "Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma." The authors claim that the title of this particular paper is dangerously misleading as it draws a premature causal link between exposure to nanoparticles and observed health effects. These types of titles, once captured in press-releases, tend to propagate a myth that all nanoparticles are dangerous. According to the authors, this practice may mislead the "public and the media into believing there is some reason to fear nanoparticles." As such, the authors caution all scientific writers to "ensure that all descriptions of nanoparticle hazards recognize the intrinsic heterogeneity of the nanoparticle hazard and discuss the uncertainty of alleged causality; ensure that there is a convincing and scientifically sustainable link between any nanoparticle exposure and any pathological outcomes putatively associated with that exposure; and, ensure that sufficient physical and chemical characterization data are provided on the nanoparticles in question to support valid data interpretation and comparison."

More information about this article is available here.


Nanotoxicity: In Vivo and In Vitro Models to Health Risks

Sahu, S.

Saura Sahu of the US FDA and Daniel Casciano of the University of Arkansas Medical Center have recently edited a book entitled "Nanotoxicity: In Vivo and In Vitro Models to Health Risks." This book, published by John Wiley & Sons, Ltd. (ISBN 978-0-470-74137-5), covers recent information regarding the safety evaluation of nanomaterials in foods, drugs, medical devices, cosmetics and other regulated products. Examples of topics covered in over 600 pages of this book include: biomarkers for nanotoxicity assessment; nanotoxicity assessment by gene expression analysis; in vivo and in vitro models for nanotoxicity testing; biological mechanisms of nanotoxicity; pharmacokinetics of nanomaterials nanotoxicology of foods, drugs, and cosmetics; health and environmental impacts of nanomaterials; safety evaluation of nanomaterials; and the implications of nanomaterials for regulatory decision making. According to Sahu and Casciano, the purpose of this 26 chapter book was to assemble current, state-of-the-art toxicological information on nanomaterials from recognized experts in a single volume. The result is a contemporary source of knowledge in nanotoxicology. While many chapters of this book will be of interest to research scientists that are currently engaged in laboratory research, much of this book will also be of interest to applied scientists including toxicologists and risk assessors evaluating the potential health risks of nanomaterials in environmental media, food, drugs, and consumer products.

More information about this book, including an excerpt, is available here.

Back to top

Hot-off-the-Presses: Peer-Reviewed Research Articles of Note

Johnson DR; Methner, MM; Kennedy, A; Steevens, JA. 2010. "Potential for Occupational Exposure to Engineered Carbon-Based Nanomaterials in Environmental Laboratory Studies." Environ. Health Perspect. 118(1):49-54.

Synopsis:

Discussion and Implications:


Porter, DW; Hubbs, AF; Mercer, RR; Wu, N; Wolfarth, MG; Sriram, K; Leonard, S; Battelli, L; Schwegler-Berry, D; Friend, S; Andrew, M; Chen, BT; Tsuruoka, S; Endo, M; Castranova, V. 2009. “Mouse Pulmonary Dose- and Time Course-Responses Induced by Exposure to Multi-Walled Carbon Nanotubes.” Toxicology. Doi: 10.1016/j.tox.2009.10.017.

Synopsis:

Discussion and Implications:

Back to top

Guest Contributor

The Need for a Comprehensive Nanoparticle Monitoring Strategy

Michael Ellenbecker, Sc.D., CIH*, and Su-Jung (Candace) Tsai, Sc.D.*

The number of companies that are either manufacturing engineered nanoparticles (ENPs) and/or incorporating them into devices is growing rapidly. In addition, research on ENPs is being performed at many university and government research labs, such as the Center for High-rate Nanomanufacturing (CHN) at the University of Massachusetts Lowell, where we work. All of those companies and labs need to worry about the potential for the exposure of their workers to ENPs and the potential for ENP releases from their facility into the surrounding environment. There is a basic problem, however, since neither OSHA nor EPA has issued any standards relevant to ENPs. Managers are left not knowing what constitutes an “acceptable” worker exposure or environmental release. In fact, there is very little guidance on what exactly should be monitored – airborne mass concentration (total, respirable, PM2.5?), particle surface area concentration, particle total number concentration, particle number concentration as a function of size, dermal exposure, etc.

There is evidence that some companies’ response to this challenge has been less than satisfactory. For example, some manufacturers of carbon nanotubes (CNTs), which are composed of carbon and a catalyst, have referenced the carbon black permissible exposure limit (PEL) in their Material Safety Data Sheet. This mass concentration, 5 mg/m3, when converted to a number concentration using a typical CNT size, yields a number concentration of about 1015 CNTs/m3. At the same time, recent research in animals has indicated that some CNTs may cause mesothelioma, when injected into the peritoneum of rodents. Mesothelioma is a fatal cancer that has been associated primarily with asbestos exposure.1,2 Thus, as a hypothetical, the asbestos PEL may be more applicable to some CNTs, not the carbon black standard; this value, 105 fibers/m3, is 1010 times lower than the carbon black standard. This is quite a range between two exposure standards that may be applicable to some CNTs, and illustrates the tremendous uncertainty that now exists as to what might constitute an “acceptable” CNT exposure to workers, or for release into the environment.

In face of this uncertainty, what are company and laboratory managers to do? Our response at the CHN, where we manage the health and safety program, is to follow a precautionary approach. We acquired a sophisticated set of instruments, which allows us to carefully monitor airborne particle concentrations over the range of diameters from 5 – 20,000 nm. We also collect samples for analysis by electron microscopy, which allows us to identify particle morphology and chemical composition. We then monitor possible exposures in our laboratories. Since nanometer-sized particles are ubiquitous, we carefully determine the background concentration, and then measure concentrations during laboratory operations. We deem any exposure that is measurably higher than the background to be unacceptable, and institute engineering and administrative controls to reduce the exposure to background levels. In addition, we train all students and staff in good practices to be followed to reduce the potential for exposure; our Best Practices document is available by contacting one of us. We have recently completed a much more comprehensive report for NIOSH on good practices to be followed by research labs working with ENPs; this document should be published shortly by NIOSH.

We recommend that all facilities with the potential for exposure to ENPs follow this approach, until more guidance is available concerning allowable exposures to specific nanoparticles. If exposures are kept to a minimum, we can avoid harm to workers health.

1Poland, et al., “Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study,” Nat. Nanotech. 3:42388 (2008).

2Takagi, et al., “Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube,” J. Toxicol. Sci. 33(1):105-16 (2008).

*Dr. Ellenbecker (ellenbec@turi.org) is a professor in the Department of Work Environment at the University of Massachusetts Lowell and Director of the Toxics Use Reduction Institute. May be contacted at the email address given above for more information.

*Dr. Tsai (candace@turi.org) is a postdoctoral researcher and Manager of Environmental Health and Safety at CHN. They are available for consultation with anyone concerned about possible ENP exposures at their facility. May be contacted at the email address given above for more information.

Back to top


© Gradient 2010. All rights reserved.
View print version